Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2008
11/13/2008CA2686336A1 Topical formulations and methods for elimination and prophylaxis of susceptible and treatment resistant strains of head lice with multiple modes of action
11/13/2008CA2686314A1 An exopolysaccharide
11/13/2008CA2686312A1 Process for preparing aromatase inhibitors
11/13/2008CA2686221A1 [4-(6-fluoro-7-methylamino-2,4-dioxo-1,4-dihydro-2h-quinazolin-3-yl)-phenyl]-5-chloro-thiophen-2-yl-sulfonylurea salts, forms and methods related thereto
11/13/2008CA2686203A1 Intravenous and oral dosing of a direct-acting and reversible p2y12 inhibitor
11/13/2008CA2686202A1 Detecting succinylacetone
11/13/2008CA2686163A1 Imidazoquinolines with immuno-modulating properties
11/13/2008CA2686157A1 Treatment of cardiovascular disease and dyslipidemia using secretory phospholipase a2 (spla2) inhibitors and spla2 inhibitor combination therapies
11/13/2008CA2686138A1 Novel macrocyclic inhibitors of hepatitis c virus replication
11/13/2008CA2686063A1 Diabetic wound healing
11/13/2008CA2686051A1 Combination therapy for the treatment of hcv infection
11/13/2008CA2685924A1 Naphthyl(ethyl)acetamides
11/13/2008CA2685876A1 Thiazoles and pyrazoles useful as kinase inhibitors
11/13/2008CA2685853A1 Composition for transmucosal delivery of polypeptides
11/13/2008CA2685845A1 Liquorice extract antimicrobial and anti-inflammatory isolates
11/13/2008CA2685840A1 Methods for differentiating pancreatic cancer from normal pancreatic function and/or chronic pancreatitis
11/13/2008CA2685726A1 Fulvene and fulvalene analogs and their use in treating cancers
11/13/2008CA2685723A1 Morphinan compounds
11/13/2008CA2685546A1 Organic compounds
11/13/2008CA2685543A1 2-heteroaryl-pyrrolo[3,4-c]pyrrole derivatives and their use as scd inhibitors
11/13/2008CA2685421A1 Oronasopharyngeally deliverable pharmaceutical composition for the prevention/alleviation and/or treatment of restless limb disorder
11/13/2008CA2685389A1 Tricyclic compounds as matrix metalloproteinase inhibitors
11/13/2008CA2685216A1 Thienopyridine and thiazolopyridine derivatives that inhibit prolyl hydroxylase activity
11/13/2008CA2684953A1 Use of s1p receptor modulator
11/13/2008CA2684938A1 Dihydropyridine derivative for treating cancer or a pre-cancerous condition and other conditions
11/13/2008CA2684926A1 Compositions comprising c-13 alkoxyether macrolide compounds and phenylpyrazole compounds
11/13/2008CA2684922A1 Cytotoxic t cell activator comprising ep4 agonist
11/13/2008CA2684908A1 Implantable system for an intervertebral disc and intervertebral disc implant
11/13/2008CA2684722A1 Combination therapy with a compound acting as a platelet adp receptor inhibitor
11/13/2008CA2684703A1 Bicyclic compound and pharmaceutical use thereof
11/13/2008CA2684693A1 9-(pyrazol-3-yl)-9h-purine-2-amine and 3-(pyraz0l-3-yl)-3h-imidazo[4,5-b]pyridin-5-amine derivatives and their use for the treatmentof cancer
11/13/2008CA2684503A1 Pyridine derivatives substituted by heterocyclic ring and phosphonoamino group, and anti-fungal agent containing same
11/13/2008CA2684186A1 N-halogenated amino acid formulations with anti-inflammatory compounds
11/13/2008CA2684091A1 Use of a naphtoic acid derivative in combination with red and/or blue light for treating acne vulgaris
11/13/2008CA2684088A1 New progesterone receptor modulators
11/13/2008CA2683821A1 Heterocyclic compounds and their use as pesticides
11/13/2008CA2683760A1 Use of bipolar trans carotenoids as a pretreatment and in the treatment of peripheral vascular disease
11/13/2008CA2683554A1 Use of hdac inhibitors for the treatment of gastrointestinal cancers
11/13/2008CA2682250A1 Ibuprofen, cyclodextrines and ternary agent complexes, and pharmaceutical uses thereof
11/13/2008CA2680833A1 Treatment of age-related macular degeneration using inhibitors of complement factor d
11/13/2008CA2680803A1 Derivatives of the aminated hydroxyquinoline class for treating cancers
11/13/2008CA2674831A1 5,6-ring annulated indole derivatives and methods of use thereof
11/13/2008CA2670303A1 (s)-n-stereoisomers of 7,8-saturated-4,5-epoxy-morphinanium analogs
11/13/2008CA2670284A1 Synthesis of compounds useful as modulators of amyloid-beta production
11/12/2008EP1990413A1 Screening method for candidate drugs
11/12/2008EP1990346A2 Process for the preparation of narcistatin prodrugs
11/12/2008EP1990343A2 Azaindoles
11/12/2008EP1990342A1 Pyridopyrazine Derivatives, Process of Manufacturing and Uses thereof
11/12/2008EP1990341A1 Triazolyl tropane derivatives as CCR5 modulators
11/12/2008EP1990337A1 Quinazoline derivatives,preparation methods and uses thereof
11/12/2008EP1990335A1 17 beta hsd type 5 inhibitor
11/12/2008EP1990058A1 Aglyco products and their use for inhibiting infection by influenza virus, and useof hexosamine precursor in schizophrenia treatment
11/12/2008EP1990055A2 Methods for pretreating a subject with extracorporeal photopheresis and/or apoptotic cells
11/12/2008EP1990054A1 Polymerase inhibitors and their use in treating tumours
11/12/2008EP1990053A1 Pharmaceutical composition for enhancing adiponectin production
11/12/2008EP1990052A1 Pharmaceutical package
11/12/2008EP1990051A1 Combinations of SSRI and estrogenic agents
11/12/2008EP1990050A1 Disinfectant ointment
11/12/2008EP1990049A2 Combination therapy of beta-blockers and non-steroidal anti-inflammatory drugs (NSAID)
11/12/2008EP1990048A2 Therapy of benign prostatic hyperplasia (bph)
11/12/2008EP1990047A1 Use of a monoterpene to treat or prevent stress
11/12/2008EP1990046A1 Condensation aerosol containing loxapine or prochlorperazine for inhalation
11/12/2008EP1990044A1 Mifepristone pharmaceutical compositions and their methods of preparation
11/12/2008EP1990040A1 Nanoparticle delivery vehicle
11/12/2008EP1989308A1 Methods and compositions to treat and detect misfolded-sod1 mediated diseases
11/12/2008EP1989305A2 Rnai-mediated inhibition of rho kinase for treatment of ocular hypertension / glaucoma
11/12/2008EP1989218A2 17-phosphorous steroid derivatives useful as progesterone receptor modulators
11/12/2008EP1989217A2 11-phosphorous steroid derivatives useful as progesterone receptor modulators
11/12/2008EP1989216A2 Diagnosis and treatment of prostate cancer
11/12/2008EP1989212A2 Treatment of hyperproliferative diseases with vinca alkaloid n-oxide and analogs
11/12/2008EP1989210A2 A2a adenosine receptor antagonists
11/12/2008EP1989208A1 New morphine compounds for pharmaceutical compositions
11/12/2008EP1989207A1 Crystalline forms of (3r,4r)-4-amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methol]piperidin-3-ol
11/12/2008EP1989206A2 Inhibitors of e1 activating enzyme
11/12/2008EP1989205A2 Thiophene-carboxamides useful as inhibitors of protein kinases
11/12/2008EP1989204A1 Pyrazoloquinolones are potent parp inhibitors
11/12/2008EP1989203A2 Alpha carbolines and uses thereof
11/12/2008EP1989202A1 Novel chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
11/12/2008EP1989201A1 Pi-3 kinase inhibitors and methods of their use
11/12/2008EP1989200A2 [4-(benzo[b]thiophen-2-yl)-pyrimidin-2-yl]-amine derivatives as ikk-beta inhibitors for the treatment of cancer and inflammatory diseases
11/12/2008EP1989198A1 2,4-diaminopyrimidine derivatives for the treatment and/or prevention of cancer, infections, inflammatory and autoimmune disorders
11/12/2008EP1989197A1 Pyrazolylquinazolinones as potassium channel openers
11/12/2008EP1989195A1 Phosphodiesterase 10 inhibitors
11/12/2008EP1989192A2 1,3-dioxane carboxylic acids
11/12/2008EP1989191A1 Glucopyranosyl-substituted benzonitrile derivatives, pharmaceutical compositions containing such compounds, their use and process for their manufacture
11/12/2008EP1989188A1 Therapeutic piperazines as pde4 inhibitors
11/12/2008EP1989187A1 2-(phenyl or heterocyclic) - 1h-phenanthro (9,10-d) imidazoles
11/12/2008EP1989186A1 Hydantoin based kinase inhibitors
11/12/2008EP1989185A1 Therapeutic compounds
11/12/2008EP1989182A1 Crystalline form of the arginine salt of perindopril, process for preparing it, and pharmaceutical compositions comprising it
11/12/2008EP1988993A2 Improved preparation of molecular imprinted polymers
11/12/2008EP1988972A2 Proteasom or ups inhibitor for treating infections with influenza viruses
11/12/2008EP1988971A2 Compositions and methods for preserving brain function
11/12/2008EP1988926A2 Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
11/12/2008EP1988924A2 New stable hyperbaric composition comprising prilocaine hcl, use of said new composition for intrathecal anaesthesia, and method for manufacturing said composition
11/12/2008EP1988910A2 Acryloyloxyethylphosphorylcholine containing polymer conjugates and their preparation
11/12/2008EP1988909A2 Use of polyethylene glycol in inflammation related topical disorders or diseases and wound healing
11/12/2008EP1988908A2 Sterilized peritoneal dialysis solutions containing heparin
11/12/2008EP1988907A2 Compositions comprising a bisphosphonate and an antifolate
11/12/2008EP1988906A2 Method for accelerating reentrainment of a circadian rhythm
1 ... 3000 3001 3002 3003 3004 3005 3006 3007 3008 3009 3010 3011 3012 3013 3014 3015 3016 3017 3018 3019 3020 ... 7860